Stock DNA
Other Industrial Products
CNY 1,911 Million (Small Cap)
48.00
NA
0.00%
-0.21
-999,999.00%
2.02
Revenue and Profits:
Net Sales:
147 Million
(Quarterly Results - Mar 2026)
Net Profit:
6 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.20%
EBIT Growth (5y)
-15.80%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
31.71%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
Price to Book Value
2.02
EV to EBIT
44.83
EV to EBITDA
27.82
EV to Capital Employed
2.28
EV to Sales
3.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.09%
ROE (Latest)
4.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
566.10
551.50
2.65%
Operating Profit (PBDIT) excl Other Income
61.60
93.10
-33.83%
Interest
4.00
4.10
-2.44%
Exceptional Items
0.40
-0.00
Consolidate Net Profit
40.30
70.00
-42.43%
Operating Profit Margin (Excl OI)
67.50%
136.00%
-6.85%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.65% vs 4.43% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -42.43% vs -15.15% in Dec 2024






